5-[1'-(decahydro-7-hydroxy-1,1,3a,7-tetramethyl-1H-cyclopropa[a]naphtalen-4-yl)-3'- methylbutyl]-2,4,6-trihydroxy-1,3-benzenedicarboxaldehyde used as drugs

摘要

The present invention relates to new compounds of formula (I) and to their use as medicaments. Preferably, the said compounds are used in the preparation of a medicament or food supplement intended for the treatment and/or prevention of ailments or pathologies ensuing from a disorder of the reuptake of the following neurotransmitters: dopamine, serotonin and/or noradrenaline.